Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial
ConclusionsAtorvastatin, administered at a fixed daily dose of 10 mg, was not beneficial in lowering lipid levels in children with SRNS; rise in serum albumin was associated with improvement in dyslipidemia.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Atorvastatin Calcium | Cardiology | Cardiovascular | Children | Cholesterol | Clinical Trials | Heart | Lipitor | Nephrotic Syndrome | Pediatrics | Statin Therapy | Urology & Nephrology | Zivast